ID   FHS040i-sh2098B
AC   CVCL_YY71
SY   iPSC - 2098B
DR   BioSample; SAMN06093663
DR   GEO; GSM2411780
DR   WiCell; fhs040i-sh2098b
DR   Wikidata; Q98126169
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 3231; CELSR2; Simple; c.*919G; dbSNP=rs12740374; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY70 ! FHS039i-sh2098A
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
RX   PubMed=28388431; DOI=10.1016/j.stem.2017.01.010;
RA   Warren C.R., O'Sullivan J.F., Friesen M., Becker C.E., Zhang X.-L.,
RA   Liu P.-C., Wakabayashi Y., Morningstar J.E., Shi X., Choi J., Xia F.,
RA   Peters D.T., Florido M.H.C., Tsankov A.M., Duberow E.A., Comisar L.,
RA   Shay J., Jiang X., Meissner A., Musunuru K., Kathiresan S.,
RA   Daheron L., Zhu J., Gerszten R.E., Deo R.C., Vasan R.S.,
RA   O'Donnell C.J., Cowan C.A.;
RT   "Induced pluripotent stem cell differentiation enables functional
RT   validation of GWAS variants in metabolic disease.";
RL   Cell Stem Cell 20:547-557.e7(2017).
//